首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

2008099

盐酸舍曲林市场：按类型、应用、分销管道和地区划分

Sertraline HCl Market, By Type, By Application, By Distribution Channel, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026年盐酸舍曲林市场规模估计为21亿美元，预计2033年将达31亿美元。预计2026年至2033年，其复合年增长率将达4.1%。

分析范围		分析详情
基准年	2025	市场规模（2026 年）	21亿美元
效能数据	2020-2024	预测期	2026-2033
预测期（2026-2033 年）复合年增长率	4.10%	预计金额（2033 年）	31亿美元

盐酸舍曲林是一种选择性血清素再回收抑制剂（SSRI）抗忧郁症。盐酸舍曲林的作用机制与其他SSRI类似，都是透过增加大脑中血清素的含量来发挥作用。血清素是一种神经传导物质，或称为化学信使，参与调节人体日常生活的许多方面，包括情绪、睡眠、奖赏、学习和记忆。研究表明，忧郁症与血清素水平低下有关。舍曲林有助于提高大脑中的血清素水平，减少化学物质失衡，从而改善患者的整体情绪。舍曲林有口服锭剂和液体两种剂型，通常每日服用一次，早晚均可。用于治疗月经焦虑症时，可以每日服用，也可以仅在月经週期的特定日期服用。

市场动态

关键市场趋势包括抗忧郁症处方量和支出增加，预计将推动预测期内的市场成长。例如，根据施普林格·自然瑞士公司2021年3月发表的报导，在新冠疫情期间（2020年1月至12月），抗忧郁症（AD）处方总量为7800万张，比2019年增加了400万张。这导致英国国家医疗服务体系（NHS，英格兰的公共医疗保健系统）的支出比2019年增加了1.39亿英镑（1.707亿美元）。仅舍曲林（一种选择性5-羟色胺再抗忧郁症，其2020年的成本就比2019年增加了1.13亿英镑（1.387亿美元）。

本报告的主要特点

本报告对全球盐酸舍曲林市场进行了详细分析，包括预测期（2026-2033 年）的市场规模和复合年增长率，以 2025 年为基准年。
此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本文檔根据以下参数介绍了全球盐酸舍曲林市场的主要企业概况：公司概况、产品系列、主要亮点、财务表现和策略。
本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
《全球盐酸舍曲林市场》报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球盐酸舍曲林市场中使用的各种策略矩阵来促进决策。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
中东
- GCC
- 以色列
- 其他中东国家
非洲
- 北非
- 中非
- 南非

第八章竞争情势

热图分析
市占率分析
- Pfizer
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Accord Biopharma
- Apotex Inc.
- Aurobindo Pharma USA
- InvaGen
- Lupin
- Camber Pharmaceuticals
- Mylan NV（a part of Viatris Inc.）
- Sun Pharmaceutical
- Wockhardt
- Alpic Biotech

第九章

分析方法
关于 Coherent Market Insights

简介目录

Product Code: CMI5355

Sertraline Hcl Market is estimated to be valued at USD 2.1 Bn in 2026 and is expected to reach USD 3.1 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.1 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.10%	2033 Value Projection:	USD 3.1 Bn

Sertraline HCl belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Sertraline HCl has the same mechanism of action as other SSRIs. It works by increasing the amount of serotonin that is available in the brain. Serotonin is a neurotransmitter, or chemical messenger, that is involved in regulating many elements of a person's daily life, including mood, sleep, rewards, learning, and memory. Research has linked depression with low levels of serotonin. Sertraline increases the amount of serotonin present in the brain, helping to reduce chemical imbalances and improve a person's overall mood. Sertraline is available as either an oral tablet or a liquid. Typically, a person takes a dose in the morning or evening, once a day. People using it to treat premenstrual dysphoric disorder may take it every day or only on select days of the month.

Market Dynamics

Key trends in the market include increasing prescription rate and expenditure for antidepressant drug which is expected to drive the market growth during the forecast period. For instance, according to an article published in Springer Nature Switzerland AG in March 2021, stated that the total number of Ads (antidepressants) prescriptions dispensed during COVID-19 pandemic (January to December 2020) were 78 million, 4 million more than in 2019 that costed the National Health Service (NHS) is the publicly funded healthcare system in England, £139 million (US $170.7 million) more than in 2019. Sertraline, an SSRI antidepressant drug, alone accounted for an extra £113 million (US $ 138.7 million) during 2020 than in 2019.

Key features of the study

This report provides an in-depth analysis of the global sertraline HCl market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sertraline HCl market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Accord Biopharma, Apotex Inc., Aurobindo Pharma USA, InvaGen, Lupin, Camber Pharmaceuticals, Mylan (a part of Viatris Inc.), Sun Pharmaceutical, Wockhardt, Alpic Biotech
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sertraline HCl market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sertraline HCl market.

Market Segmentation

By Type
- 25 mg
- 50 mg
- 100 mg
- Others
By Application
- Obsessive-Compulsive Disorder
- Depression
- Panic Disorder
- Premenstrual Dysphoric Disorder
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Accord Biopharma
- Apotex Inc.
- Aurobindo Pharma USA
- InvaGen
- Lupin
- Camber Pharmaceuticals
- Mylan N.V. (a Part of Viatris Inc.)
- Sun Pharmaceutical
- Wockhardt
- Alpic Biotech

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Regulatory Scenario
Market Trends
Key Developments
Epidemiology
PEST Analysis
Collaboration and Acquisition
Porters Analysis
Pipeline Analysis

4. Global Sertraline HCL Market, By Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
25 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
100 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Sertraline HCL Market, By Application, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Obsessive-Compulsive Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Panic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Premenstrual Dysphoric Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Sertraline HCL Market, By Distribution channel, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Sertraline HCL Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Pfizer
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Accord Biopharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Apotex Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aurobindo Pharma USA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- InvaGen
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Lupin
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Camber Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mylan N.V. (a part of Viatris Inc.)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sun Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Wockhardt
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Alpic Biotech
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies

9. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

盐酸舍曲林市场：按类型、应用、分销管道和地区划分

Sertraline HCl Market, By Type, By Application, By Distribution Channel, By Geography

市场动态